<DOC>
	<DOCNO>NCT02629757</DOCNO>
	<brief_summary>This study conduct help determine whether β-elemene maintain treatment complete remission patient newly diagnose malignant glioma follow standard treatment , able delay tumor growth , impact long people newly diagnose high-grade glioma .</brief_summary>
	<brief_title>A Study β-elemene Maintain Treatment Complete Remission Patients Newly Diagnosed Malignant Gliomas Following Standard Treatment</brief_title>
	<detailed_description>This study conduct help determine whether β-elemene maintain treatment complete remission patient newly diagnose malignant glioma follow standard treatment , able delay tumor growth , impact long people newly diagnose high-grade glioma . β-elemene give 600mg/d , d1-14 , q28 day 6 cycle .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<criteria>Page 3 4 [ DRAFT ] Arms Assigned Interventions Temodar Experimental : temozolomide +αIFN Four week radiotherapy , patient receive 6 cycle temozolomide plus αIFN αIFN： 3mIU ( 3million ) Day1,3,5 28 day TMZ：150 mg/m^2 daily Days 26 28 day study cycle 200 mg/m^2 daily subsequent cycle Drug : Temozolomide dose 200 mg/m2 ( 150 mg/m2 first cycle ) daily 5 consecutive day , repeat every 28 day Other Names : • Temodar Drug : αIFN 3mIU ( 3million ) D1，3，5 Other Names : • INTRONA Outcome Measures Primary Outcome Measure : 1 . Overall survival [ Time Frame : 5year ] [ Safety Issue : No ] Secondary Outcome Measure : 2 . Quality life [ Time Frame : 5year ] [ Safety Issue : No ] Eligibility Minimum Age : 18 Years Maximum Age : 75 Years Gender : Both Accepts Healthy Volunteers ? : No Criteria : Age : 18 year 75 year complete remission patient newly diagnose WHO IIIIV glioma follow standard treatment Karnofsky Performance Score ≥ 60 Adequate bone marrow , liver renal function Ability subject understand character individual consequence clinical trial Written inform consent anticipate survival ≥2 month Refusal participate study Known hypersensitivity contraindication temozolomide Incompletely radiation Pregnant lactating female Malignant tumor brain tumor Contraindicated MRI examination Unable comply followup study trial Purulent chronic infect wound Uncontrolled psychotic disorder epilepsy progression disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>High-grade glioma</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>β-elemene</keyword>
</DOC>